Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Secret Squirrels hit! -- Ignore unavailable to you. Want to Upgrade?

To: Wayne Rumball who wrote (4390)	2/4/1999 8:45:00 PM
From: Trumptown	Read Replies (1) \| Respond to of 12872

IDTC - "Back to $40 is a possibility" - and then some!:) IMGN - CNN-fn interview did happen...one yahoo's take on it... "I have only been a shareholder for several months and have never watched Cnn-Fn, or have previously seen Mitch. I am therefore, far from being able to offer expert analysis of his interview. From the outset he appeared to be fidgety and a little stand offish. Kind of presented himself as someone who really didn't want to be interviewed. He made it clear that he did not wish to divulge the entire scope of the financials related to the deal. He did confirm that there would be a sizeable amount of upfront money, but would not commit further. After some further probing by the interviewer, he estimated that it takes approximately 200 million to take a drug of that type from the initial stages to approval. He also mentioned the fast track schedule of 180 days. Mitch then spoke about the science of the drug, where it was obvious he felt more comfortable. All in all, I was not overly impressed with his presentation. I felt he could have at least looked like an interested party with a little enthusiasm. Maybe that is the way Mitch is, but as far as I am concerned he did a poor job of presenting the deal. HO Hum, as a matter of fact. I would be interested to see other takes on the interview."